Maprouneacin, a new daphnane diterpenoid with potent antihyperglycemic activity from Maprounea africana

J Nat Prod. 1999 Feb;62(2):345-7. doi: 10.1021/np980356c.

Abstract

Bioassay-guided fractionation of the EtOH extract of M. africana, using the in vivo noninsulin-dependent diabetes mellitus db/db mouse model, resulted in the isolation of the new daphnane-type diterpenoid maprouneacin (2). Compound 2 showed potent glucose-lowering properties when given by the oral route.

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Body Weight / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diterpenes / isolation & purification
  • Diterpenes / pharmacology
  • Diterpenes / therapeutic use*
  • Feeding Behavior / drug effects
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Mice

Substances

  • Blood Glucose
  • Diterpenes
  • Hypoglycemic Agents
  • maprouneacin